179 related articles for article (PubMed ID: 33659867)
1. Comprehensive Assessment of Protein and Excipient Stability in Biopharmaceutical Formulations Using
Bramham JE; Podmore A; Davies SA; Golovanov AP
ACS Pharmacol Transl Sci; 2021 Feb; 4(1):288-295. PubMed ID: 33659867
[TBL] [Abstract][Full Text] [Related]
2. NMR spectroscopy as a characterization tool enabling biologics formulation development.
Ma J; Pathirana C; Liu DQ; Miller SA
J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923
[TBL] [Abstract][Full Text] [Related]
3. Characterizing monoclonal antibody formulations in arginine glutamate solutions using
Kheddo P; Cliff MJ; Uddin S; van der Walle CF; Golovanov AP
MAbs; 2016 Oct; 8(7):1245-1258. PubMed ID: 27589351
[TBL] [Abstract][Full Text] [Related]
4. Ranking mAb-excipient interactions in biologics formulations by NMR spectroscopy and computational approaches.
Zhang C; Gossert ST; Williams J; Little M; Barros M; Dear B; Falk B; Kanthe AD; Garmise R; Mueller L; Ilott A; Abraham A
MAbs; 2023; 15(1):2212416. PubMed ID: 37218059
[TBL] [Abstract][Full Text] [Related]
5. Binding of excipients is a poor predictor for aggregation kinetics of biopharmaceutical proteins.
Zalar M; Svilenov HL; Golovanov AP
Eur J Pharm Biopharm; 2020 Jun; 151():127-136. PubMed ID: 32283214
[TBL] [Abstract][Full Text] [Related]
6. An Evaluation of the Potential of NMR Spectroscopy and Computational Modelling Methods to Inform Biopharmaceutical Formulations.
Pandya A; Howard MJ; Zloh M; Dalby PA
Pharmaceutics; 2018 Sep; 10(4):. PubMed ID: 30248922
[TBL] [Abstract][Full Text] [Related]
7. Investigation of excipients impact on polysorbate 80 degradation in biopharmaceutical formulation buffers.
Bai L; Zhang Y; Zhang C; Lu Y; Li Z; Huang G; Meng B
J Pharm Biomed Anal; 2023 Sep; 233():115496. PubMed ID: 37285658
[TBL] [Abstract][Full Text] [Related]
8. Profiling Insulin Oligomeric States by
Falk BT; Liang Y; McCoy MA
J Pharm Sci; 2020 Jan; 109(1):922-926. PubMed ID: 31449814
[TBL] [Abstract][Full Text] [Related]
9. Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HPβCD): Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies.
Zhang H; Hong S; Tan SSK; Peng T; Goh LYH; Lam KH; Chow KT; Gokhale R
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235038
[TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanism of Antimicrobial Excipient-Induced Aggregation in Parenteral Formulations of Peptide Therapeutics.
Li M; Falk BT; Lu X; Schroder R; Mccoy M; Xu W; Yin DH; Gindy ME; D'Addio SM; Su Y
Mol Pharm; 2022 Sep; 19(9):3267-3278. PubMed ID: 35917158
[TBL] [Abstract][Full Text] [Related]
11. Stability of a high-concentration monoclonal antibody solution produced by liquid-liquid phase separation.
Bramham JE; Davies SA; Podmore A; Golovanov AP
MAbs; 2021; 13(1):1940666. PubMed ID: 34225583
[TBL] [Abstract][Full Text] [Related]
12. Assessing Photostability of mAb Formulations In Situ Using Light-Coupled NMR Spectroscopy.
Bramham JE; Wang Y; Moore SA; Golovanov AP
Anal Chem; 2024 Jun; 96(24):9935-9943. PubMed ID: 38847283
[TBL] [Abstract][Full Text] [Related]
13. Water Proton NMR: A Tool for Protein Aggregation Characterization.
Taraban MB; DePaz RA; Lobo B; Yu YB
Anal Chem; 2017 May; 89(10):5494-5502. PubMed ID: 28440620
[TBL] [Abstract][Full Text] [Related]
14. Trends on Analytical Characterization of Polysorbates and Their Degradation Products in Biopharmaceutical Formulations.
Martos A; Koch W; Jiskoot W; Wuchner K; Winter G; Friess W; Hawe A
J Pharm Sci; 2017 Jul; 106(7):1722-1735. PubMed ID: 28302541
[TBL] [Abstract][Full Text] [Related]
15. Suppression of Electrostatic Mediated Antibody Liquid-Liquid Phase Separation by Charged and Noncharged Preferentially Excluded Excipients.
Banks DD; Cordia JF
Mol Pharm; 2021 Mar; 18(3):1285-1292. PubMed ID: 33555888
[TBL] [Abstract][Full Text] [Related]
16. Effects of polyol excipient stability during storage and use on the quality of biopharmaceutical formulations.
Sun MF; Liao JN; Jing ZY; Gao H; Shen BB; Xu YF; Fang WJ
J Pharm Anal; 2022 Oct; 12(5):774-782. PubMed ID: 36320601
[TBL] [Abstract][Full Text] [Related]
17. Selective suppression of excipient signals in 2D
Arbogast LW; Delaglio F; Tolman JR; Marino JP
J Biomol NMR; 2018 Dec; 72(3-4):149-161. PubMed ID: 30483914
[TBL] [Abstract][Full Text] [Related]
18. High-throughput screening and stability optimization of anti-streptavidin IgG1 and IgG2 formulations.
Alekseychyk L; Su C; Becker GW; Treuheit MJ; Razinkov VI
J Biomol Screen; 2014 Oct; 19(9):1290-301. PubMed ID: 25023322
[TBL] [Abstract][Full Text] [Related]
19. The influence of water on the stability of lyophilized formulations with inositol and mannitol as excipients.
Terakita A; Matsunaga H; Handa T
Chem Pharm Bull (Tokyo); 2009 May; 57(5):459-63. PubMed ID: 19420775
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
